Company intelligence / Profile preview

Trident Bio Consulting

Ownership: Private
Development stage: Other

Overview

Trident Bio Consulting is a specialized consultancy providing clinical development services to life sciences organizations with a focus on hematology and oncology. The founder has led successful regulatory filings for major therapies including CAR-T cell therapy (Tecartus™) and contributed to approvals at leading biotech companies. The firm offers expertise spanning preclinical through IND-enabling studies, execution of clinical trials, and regulatory strategy.

Modalities: Small moleculeBiologicmRNA-based drugsCell therapy (CAR-T)
Industry: Contract Research Organization

Beyond the preview

Go deeper on Trident Bio Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trident Bio Consulting.

Explore the full profile